Updated worldwide glass market study 2024 available now for flat, container glass and tableware

We have updated our international studies on flat glass, container glass and tableware for 2024.

This unique software provides a global overview about glass producers and technical details. Easy to use and clear tables summarize information and data about glass makers such as: Glass types: flat glass, container glass, tableware, production capacities in regions and countries, number of furnaces, furnace types, year of construction, glass types and sub-types, products, project information, special news and downloads.

Further databases supplying demoscopic data and import and export data complete the market survey. Based on these data, prepare individual country profiles with information about local production capacities, local market sizes and expected demand in the future.

Request your offer via plants.glassglobal.com.

Updated container glass study 2024

X

Updated float glass study 2024

X

Further glass studies and reports 2024

X

Liste d´entreprises

INFO

Voici les informations fondamentales de l´entreprise. Cette entreprise a préparé d´autres informations f.ex le site internet, numéros de téléphone, télecopie, contacts, histoire et données géneriques.

Afin de recevoir ces informations en ligne ou pour les avoir imprimés, il faut avoir un "Profile Access" à glassglobal.com valide. Voir conditions ici:  Price Info .

login



Contact

Adresse SCHOTT Xinkang Pharmaceutical Packaging Co., Ltd
No.8 Zuoku Industrial Zone,
Huzhen Town, Jinyun County
321404 Zhejiang Province
Pays République du Peuple Chine
E-mail Get in contact with SCHOTT Xinkang Pharmaceutical Packaging Co., Ltd

Produits ou Machines

Marketed under the brand name FIOLAX®, SCHOTT borosilicate glass has been the gold standard for pharmaceutical packaging since it was first developed by the company’s founder Otto Schott in 1883. The material is highly inert and protects against any drug-container interaction, making it ideal for COVID-19 vaccines and other life-saving drugs.

SCHOTT sells the glass to third-party packaging manufacturers, but also converts the tubes to vials and other pharmaceutical containers in-house. Pharmaceutical vials made by SCHOTT are used in 75% of COVID-19 vaccine projects around the world.

Borosilicate glass, known under the SCHOTT brand name FIOLAX®, has been the preferred choice of material for pharmaceutical packaging since the company’s founder Otto Schott first developed it around 1890. The highly inert glass protects drugs from unwanted drug-container interactions, making it an ideal packaging material for life-saving drugs. More than 90% of all approved COVID-19 vaccines rely on SCHOTT’s glass tubing.

The manufacturing site will support the move away from the low borosilicate glass (so called 7.0 glass type) to the higher quality middle borosilicate glass (so called 5.0 glass type), which is already well established globally.